KF
BLRX

Krilogy Financial’s BioLineRX BLRX Stock Holding History

Krilogy Financial’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2
Closed -$1K – 209
2018
Q1 		$1K Hold
2
– – ﹤0.01% 725
2017
Q4 		$1K Hold
2
– – ﹤0.01% 727
2017
Q3 		$1K Hold
2
– – ﹤0.01% 765
2017
Q2 		$1K Hold
2
– – ﹤0.01% 688
2017
Q1 		$1K Hold
2
– – ﹤0.01% 672
2016
Q4 		$1K Hold
2
– – ﹤0.01% 672
2016
Q3 		$1K Hold
2
– – ﹤0.01% 694
2016
Q2 		$1K Hold
2
– – ﹤0.01% 706
2016
Q1 		$1K Hold
2
– – ﹤0.01% 635
2015
Q4 		$1K Hold
2
– – ﹤0.01% 398
2015
Q3 		$2K Buy
+2
New +$2.13K ﹤0.01% 543

Other funds holding BLRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BCA
Benchmark Capital Advisors New York $101M AUM 0.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Krilogy Financial's BLRX Position: Q2 2018 in Review

Krilogy Financial sold out of BioLineRX (BLRX) in Q2 2018, closing a stake of 2 shares — an estimated $1K sold.

Krilogy Financial first reported a position in BLRX in Q3 2015 and held it in 11 quarters. The position peaked at $2K in Q3 2015. 25 funds tracked by Wall St. Rank hold BLRX as of Q2 2018.

  • Krilogy Financial reported no remaining BioLineRX position as of Q2 2018 after selling out during the quarter.
  • Krilogy Financial sold 2 BioLineRX shares in Q2 2018, an estimated $1K.
  • Krilogy Financial first reported a position in BioLineRX in Q3 2015 and held it in 11 quarters.
  • Krilogy Financial's BioLineRX position peaked at $2K in Q3 2015.
  • 25 funds tracked by Wall St. Rank held BioLineRX as of Q2 2018.

Based on Krilogy Financial's 13F filing for Q2 2018, filed 15 Aug 2018.